| |
| Issue |
Title |
| |
| Vol 15, No 2 (2022) |
The current state of the veterinary drugs market in the Tyumen Region |
Abstract
PDF (Rus)
|
|
V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina |
| |
| Vol 15, No 1 (2022) |
Pharmacoepidemiological analysis of medication consumption in a multidepartmental hospital as an element of medical care quality management and the basis for assessing import substitution |
Abstract
PDF (Rus)
|
|
O. V. Zhukova, O. V. Ruina, M. V. Khazov, T. M. Konyshkina, E. A. Rodin, D. K. Lipatov |
| |
| Vol 15, No 1 (2022) |
The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 |
Abstract
PDF (Rus)
|
|
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova |
| |
| Vol 15, No 1 (2022) |
Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation |
Abstract
PDF (Rus)
|
|
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova, I. Yu. Torshin |
| |
| Vol 15, No 1 (2022) |
Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation |
Abstract
PDF (Rus)
|
|
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg |
| |
| Vol 15, No 1 (2022) |
Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom |
Abstract
PDF (Rus)
|
|
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich |
| |
| Vol 15, No 1 (2022) |
Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies |
Abstract
PDF (Rus)
|
|
K. A. Perova, D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, N. Z. Musina |
| |
| Vol 14, No 4 (2021) |
Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy |
Abstract
PDF (Rus)
|
|
N. А. Avxentyev, Yu. V. Makarova, V. V. Kadyshev |
| |
| Vol 14, No 4 (2021) |
Analysis of the consumption volumes of antithrombotic drugs used for pharmacotherapy of atrial fibrillation in Saratov Region |
Abstract
PDF (Rus)
|
|
А. V. Sokolov, О. V. Reshet’ko |
| |
| Vol 14, No 4 (2021) |
Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova |
| |
| Vol 14, No 4 (2021) |
Development of the system of state financing of Compulsory Health Insurance |
Abstract
PDF (Rus)
|
|
А. V. Larionov, S. V. Russkikh, S. V. Maslennikov |
| |
| Vol 14, No 4 (2021) |
Features of intellectual property protection mechanisms on the example of orphan drugs circulation |
Abstract
PDF (Rus)
|
|
D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin |
| |
| Vol 14, No 4 (2021) |
Application of medical products: mandatory requirements, supervision of their compliance |
Abstract
PDF (Rus)
|
|
O. A. Makhova |
| |
| Vol 14, No 3 (2021) |
Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines |
Abstract
PDF (Rus)
|
|
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva |
| |
| Vol 14, No 3 (2021) |
Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases |
Abstract
PDF (Rus)
|
|
O. L. Zadvornaya, A. N. Pishchita |
| |
| Vol 14, No 3 (2021) |
Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital |
Abstract
PDF (Rus)
|
|
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva |
| |
| Vol 14, No 3 (2021) |
Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer |
Abstract
PDF (Rus)
|
|
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova |
| |
| Vol 14, No 3 (2021) |
Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer |
Abstract
PDF (Rus)
|
|
Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova |
| |
| Vol 14, No 3 (2021) |
COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation |
Abstract
PDF (Rus)
|
|
D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy |
| |
| Vol 14, No 2 (2021) |
Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev |
| |
| Vol 14, No 2 (2021) |
Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA |
Abstract
PDF (Rus)
|
|
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev |
| |
| Vol 14, No 2 (2021) |
Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome |
Abstract
PDF (Rus)
|
|
M. A. Chernyavskaya, I. A. Narkevich |
| |
| Vol 14, No 2 (2021) |
Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting |
Abstract
PDF (Rus)
|
|
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov |
| |
| Vol 14, No 2 (2021) |
Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region |
Abstract
PDF (Rus)
|
|
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin |
| |
| Vol 14, No 2 (2021) |
Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care |
Abstract
PDF (Rus)
|
|
D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh |
| |
| Vol 14, No 2 (2021) |
Effect of vitamin D intake on quality of life parameters in office workers |
Abstract
PDF (Rus)
|
|
A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova |
| |
| Vol 14, No 2 (2021) |
Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price |
Abstract
PDF (Rus)
|
|
D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov |
| |
| Vol 14, No 2 (2021) |
Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova |
| |
| Vol 14, No 2 (2021) |
Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation |
Abstract
PDF (Rus)
|
|
D. G. Shchurov, V. S. Dombrovskiy |
| |
| Vol 14, No 3 (2021) |
Health economic evaluation of risdiplam in patients with spinal muscular atrophy |
Abstract
PDF (Rus)
|
|
А. S. Kolbin, А. А. Kurylev, Yu. Е. Balykina, М. А. Proskurin, S. А. Mishinova |
| |
| Vol 14, No 1 (2021) |
Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District |
Abstract
PDF (Rus)
|
|
M. S. Soboleva, E. E. Loskutova |
| |
| Vol 14, No 1 (2021) |
Differences in the standardization of medicinal products based on extracts of chondroitin sulfate |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina |
| |
| Vol 14, No 1 (2021) |
Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy |
Abstract
PDF (Rus)
|
|
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov |
| |
| Vol 14, No 1 (2021) |
Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 |
Abstract
PDF (Rus)
|
|
O. V. Zhukova, A. L. Khokhlov |
| |
| Vol 14, No 1 (2021) |
Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova |
| |
| Vol 13, No 4 (2020) |
Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard |
Abstract
PDF (Rus)
|
|
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova |
| |
| Vol 13, No 4 (2020) |
Regional aspects for assessing the effectiveness of resources management in medical organizations |
Abstract
PDF (Rus)
|
|
О. A. Volkova, E. V. Smirnova, S. N. Cherkasov |
| |
| Vol 13, No 4 (2020) |
Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy |
Abstract
PDF (Rus)
|
|
I. N. Dyakov, S. R. Varfolomeеva |
| |
| Vol 13, No 4 (2020) |
Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova |
| |
| Vol 13, No 4 (2020) |
Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia |
Abstract
PDF (Rus)
|
|
V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura |
| |
| Vol 13, No 4 (2020) |
The social-economic burden of spinal muscular atrophy in Russia |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina |
| |
| Vol 13, No 4 (2020) |
Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system |
Abstract
PDF (Rus)
|
|
T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky |
| |
| Vol 13, No 4 (2020) |
Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm |
Abstract
PDF (Rus)
|
|
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov |
| |
| Vol 13, No 3 (2020) |
Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making |
Abstract
PDF (Rus)
|
|
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy |
| |
| Vol 13, No 3 (2020) |
Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov |
| |
| Vol 13, No 3 (2020) |
The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation |
Abstract
PDF (Rus)
|
|
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova |
| |
| Vol 13, No 3 (2020) |
Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 |
Abstract
PDF (Rus)
|
|
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina |
| |
| Vol 13, No 3 (2020) |
Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up |
Abstract
PDF (Rus)
|
|
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko |
| |
| Vol 13, No 3 (2020) |
The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups |
Abstract
PDF (Rus)
|
|
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan |
| |
| Vol 13, No 2 (2020) |
Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva |
| |
| 101 - 150 of 164 Items |
<< < 1 2 3 4 > >>
|
